Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium

J Am Coll Cardiol. 2010 May 25;55(21):2330-42. doi: 10.1016/j.jacc.2009.12.055.

Abstract

Objectives: We investigated changes in Na(+) currents (I(Na)) in permanent (or chronic) atrial fibrillation (AF) and the effects of I(Na) inhibition using ranolazine (Ran) on arrhythmias and contractility in human atrial myocardium.

Background: Electrical remodeling during AF is typically associated with alterations in Ca(2+) and K(+) currents. It remains unclear whether I(Na) is also altered.

Methods: Right atrial appendages from patients with AF (n = 23) and in sinus rhythm (SR) (n = 79) were studied.

Results: Patch-clamp experiments in isolated atrial myocytes showed significantly reduced peak I(Na) density ( approximately 16%) in AF compared with SR, which was accompanied by a 26% lower expression of Nav1.5 (p < 0.05). In contrast, late I(Na) was significantly increased in myocytes from AF atria by approximately 26%. Ran (10 mumol/l) decreased late I(Na) by approximately 60% (p < 0.05) in myocytes from patients with AF but only by approximately 18% (p < 0.05) in myocytes from SR atria. Proarrhythmic activity was elicited in atrial trabeculae exposed to high [Ca(2+)](o) or isoprenaline, which was significantly reversed by Ran (by 83% and 100%, respectively). Increasing pacing rates from 0.5 to 3.0 Hz led to an increase in diastolic tension that could be significantly decreased by Ran in atria from SR and AF patients.

Conclusions: Na(+) channels may contribute to arrhythmias and contractile remodeling in AF. Inhibition of I(Na) with Ran had antiarrhythmic effects and improved diastolic function. Thus, inhibition of late I(Na) may be a promising new treatment option for patients with atrial rhythm disturbances and diastolic dysfunction.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetanilides / pharmacology*
  • Aged
  • Analysis of Variance
  • Atrial Appendage / drug effects
  • Atrial Appendage / metabolism
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / surgery
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism
  • Calcium Signaling
  • Cardiac Surgical Procedures / methods
  • Catheter Ablation / methods
  • Female
  • Heart Atria / drug effects
  • Heart Atria / physiopathology
  • Humans
  • Male
  • Myocardial Contraction / physiology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / physiology
  • Organ Culture Techniques
  • Piperazines / pharmacology*
  • Probability
  • Ranolazine
  • Reference Values
  • Sampling Studies
  • Sodium Channels / drug effects*
  • Sodium Channels / metabolism

Substances

  • Acetanilides
  • Calcium Channels
  • Piperazines
  • Sodium Channels
  • Ranolazine